Latest Breaking News On - Onyx pharmaceuticals - Page 5 : comparemela.com

Enliven Therapeutics Appoints Dr Lori Kunkel to Board of Directors

BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precisio.

United statesUniversity of southern californiaSan diegoSam kintzLori kunkelEli lillyLos angelesDivision of hematology oncologyEnliven therapeutics incBoard of directors nurix therapeutics incTherapeutics incUniversity of californiaOnyx pharmaceuticalsPharmaceuticals incCompany nasdaqProteolix inc

Enliven Therapeutics Appoints Dr Lori Kunkel to Board of Directors

Enliven Therapeutics Appoints Dr Lori Kunkel to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of southern californiaUnited statesSan diegoSam kintzLos angelesEli lillyLori kunkelEnliven therapeutics incCompany nasdaqUniversity of californiaBoard of directors nurix therapeutics incDivision of hematology oncologyPharmaceuticals incOnyx pharmaceuticalsTherapeutics incProteolix inc

Takeda welcomes new leader—Chutes & Ladders

Takeda welcomes new leader—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesSan diegoMaartje verschuurAstellas pharmaEric adlerStuart milsteinKerry benenatoNeil josephsonChris emeryAmy burroughsGabrielle massonNicolas chornetasJoanne bryceJean franchiRoche genentech

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M D , M S , as Vice President, Clinical Development

WALTHAM, Mass., Feb. 06, 2024 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment.

United statesUniversity of cincinnatiDebora bartonJoyce allaireHeather savelleLife edit therapeutics incTranslational researchAmgen incGlobe newswire tscan therapeutics incOnyx pharmaceuticals incEarly development at elevatebioRubius therapeutics incClinical developmentDrexel university college of medicineLifesci advisorsSecurities exchange

Ted Love, MD, Joins Gilead Sciences Board of Directors

FOSTER CITY, Calif. (BUSINESS WIRE) Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Ted Love, MD, has been appointed to the company’s Board of Directors.Dr. Love is currently chair of the Board of Directors of the Biotechnology Innovation Organization and serves on the Boards of Directors of Royalty Phar.

United statesFoster cityTechnical operations at onyx pharmaceuticals incNuvelo incGilead sciencesGilead sciences incDevelopment at theravance biopharma incYale school of medicineWilliame proudford sickle cell fundGlobal blood therapeutics incService awardAssociation of black cardiologistsTed loveBiotechnology innovation organizationRoyalty pharmaChief executive officer